Hospital drug specialist Clinigen floats on AIM
The pharmaceuticals group Clinigen announced a rare flotation on the AIM junior market yesterday, raising £50m.
Clinigen, which specialises in hospital-only medicines, will start trading on the junior market next Tuesday, with its placing at 164p a share giving it a market capitalisation of £135m.
The company's medicines include the anti-virus treatment Foscavir which it bought from AstraZeneca in 2010. Peter George, the chief executive, said Clinigen intended to acquire and build up sales of further niche hospital-only drugs.
"After a period of sustained international growth, a listing of our shares is key and the next logical step in our development," he said. "We aim to maintain our strong growth record."
- 1 Woman 'suffocates newborn baby in plastic bag and puts it in her desk minutes after giving birth'
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
- 5 Chinese student carries disabled friend to school every day for three years
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband
The sickening truth about food banks that the Tories don't want you to know
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
General Election 2015: Britain would become a 'communist dictatorship' under Ed Miliband and Nicola Sturgeon, claims wife of Michael Gove
iJobs Money & Business
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...